Hudson Bay Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-400,000
Closed -$21.3M 740
2020
Q3
$21.3M Buy
+400,000
New +$23.8M 0.32% 47
2020
Q2
Sell
-27,500
Closed -$1.08M 594
2020
Q1
$1.08M Sell
27,500
-57,500
-68% -$3.36M 0.03% 317
2019
Q4
$5.05M Sell
85,000
-200,000
-70% -$10.8M 0.11% 174
2019
Q3
$15.2M Buy
285,000
+105,000
+58% +$5.39M 0.42% 45
2019
Q2
$9.2M Buy
180,000
+79,536
+79% +$3.7M 0.21% 94
2019
Q1
$5.2M Buy
+100,464
New +$4.87M 0.07% 267
2017
Q4
Sell
-272,398
Closed -$14.2M 569
2017
Q3
$14.2M Buy
272,398
+81,638
+43% +$4.55M 0.35% 69
2017
Q2
$11.2M Buy
190,760
+140,760
+282% +$7.31M 0.22% 94
2017
Q1
$2.29M Sell
50,000
-145,295
-74% -$7.23M 0.03% 431
2016
Q4
$10.3M Buy
+195,295
New +$9.45M 0.21% 99

Other funds holding SYNH

Hudson Bay Capital Management's SYNH Position: Q4 2020 in Review

Hudson Bay Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2020, closing a stake of 400,000 shares — an estimated $21.3M sold.

Hudson Bay Capital Management first reported a position in SYNH in Q4 2016 and held it in 10 quarters. The position peaked at $21.3M in Q3 2020. 313 funds tracked by Wall St. Rank hold SYNH as of Q4 2020.

  • Hudson Bay Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 400,000 Syneos Health, Inc. Class A Common Stock shares in Q4 2020, an estimated $21.3M.
  • Hudson Bay Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2016 and held it in 10 quarters.
  • Hudson Bay Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $21.3M in Q3 2020.
  • 313 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2020.

Based on Hudson Bay Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.